Kayla Shipley, MD
Emergency Medicine · Lafayette
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Coolidge Emergency Group LLC · 25 clinicians in this group
Hospitals listed: Ochsner Lafayette General Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Shipley’s office at (337) 289-7991 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ochsner Lafayette General Medical CenterLafayette, LAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Ochsner Health System, which runs 36 hospitals in 3 statesPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.34 (1.1 to 1.58), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.6 (1.09 to 2.11) · 7,930 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.355, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.117, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.252, Oct 2024 – Sep 2025
See every measure and the patient survey for Ochsner Lafayette General Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.34 (1.1 to 1.58) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.6 (1.09 to 2.11) · 7,930 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.355 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.117 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.252 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.26 (0.38 to 2.13) · 1,835 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 169.88 (126.89 to 212.86) · 144 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 206 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.2 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 565 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 482 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.2 · 587 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.3 · 4,966 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.04 to 0.42) · 9,408 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 9,587 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.42 to 4.78) · 3,099 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.42 (1.09 to 3.75) · 1,587 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.7 (1.47 to 3.93) · 3,024 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.34 (6.07 to 14.61) · 1,564 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.55 (2.61 to 8.5) · 1,601 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.78 (0.37 to 3.19) · 437 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.5 · 338 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.044 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.4 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.447 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 338 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.5 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.3 · 233 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.2 · 662 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2.2 · 522 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 664 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.7 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (9 to 14) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 315 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.1 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 253 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.4 (10.8 to 18.8) · 334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 751 cases | No different | Jan 2024 – Dec 2024 |
What patients said (822 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 73% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 70% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$92,674
Medicare paid this office $92,674 for 580 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Emergency department visit with high level of medical decision making | 407 | $58,158 | $140 |
| Critical care, first 30-74 minutes | 152 | $26,498 | $172 |
| Emergency department visit with moderate level of medical decision making | 29 | $3,173 | $96 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 15 | $1,722 | $115 |
Who their Medicare patients are
580 Original Medicare patients in 2024. Average age 75 · Under 65 13% · 85 and older 21% · Women 53% · Also on Medicaid 28% · Health risk score 2.47. Above the middle of the specialty; the typical emergency medicine clinician is at 2.01.
Conditions among them: High blood pressure 75% · Coronary heart disease 53% · Diabetes 45% · Depression 44% · Heart failure 43% · Chronic kidney disease 43% · Atrial fibrillation 40% · Stroke 31% · COPD 28% · Dementia 24% · Cancer 20%.
The office billed $1,573,046, Medicare allowed $116,158 and paid $92,674; for 664 services of 28 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 580 | 664 | 75 | 2.47 | $1,573,046 | $92,674 |
| 2023 | 548 | 640 | 75 | 2.12 | $1,405,749 | $85,886 |
| 2022 | 629 | 704 | 73 | 2.41 | $1,555,500 | $108,459 |
| 2021 | 707 | 815 | 72 | 2.50 | $1,813,097 | $130,873 |
| 2020 | 1,020 | 1,178 | 72 | 2.50 | $2,569,151 | $170,287 |
| 2019 | 1,314 | 1,539 | 71 | 2.67 | $3,306,353 | $203,978 |
| 2018 | 1,049 | 1,240 | 72 | 2.58 | $2,499,285 | $158,430 |
| 2017 | 1,072 | 1,355 | 70 | 2.50 | $2,441,728 | $162,632 |
| 2016 | 263 | 316 | 68 | 2.11 | $572,587 | $39,064 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Emergency department visit with high level of medical decision making | 390 | $56,024 | $139 |
| Critical care, first 30-74 minutes | 117 | $19,962 | $169 |
| Emergency department visit with moderate level of medical decision making | 47 | $6,101 | $94 |
2022: 4 services
| Emergency department visit with high level of medical decision making | 462 | $74,863 | $158 |
| Critical care, first 30-74 minutes | 123 | $25,046 | $199 |
| Emergency department visit with moderate level of medical decision making | 44 | $4,458 | $97 |
| Emergency department visit with low level of medical decision making | 14 | $841 | $60 |
2021: 5 services
| Emergency department visit with high level of medical decision making | 513 | $88,117 | $163 |
| Critical care, first 30-74 minutes | 153 | $32,621 | $209 |
| Emergency department visit with moderate level of medical decision making | 37 | $3,884 | $100 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 18 | $2,262 | $119 |
| Emergency department visit with low level of medical decision making | 15 | $775 | $52 |
2020: 6 services
| Emergency department visit with high level of medical decision making | 743 | $113,466 | $144 |
| Critical care, first 30-74 minutes | 210 | $41,129 | $194 |
| Emergency department visit with moderate level of medical decision making | 66 | $6,547 | $96 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 26 | $3,190 | $123 |
| Manual attempt to restore blood circulation and breathing | 13 | $2,026 | $156 |
| Emergency department visit with low level of medical decision making | 20 | $1,193 | $52 |
2019: 6 services
| Emergency department visit with high level of medical decision making | 1,028 | $149,108 | $135 |
| Critical care, first 30-74 minutes | 200 | $36,454 | $175 |
| Emergency department visit with moderate level of medical decision making | 93 | $8,195 | $88 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 28 | $3,202 | $114 |
| Emergency department visit with low level of medical decision making | 23 | $1,112 | $44 |
| Simple repair of surface wound of scalp, neck, underarms, trunk, arms, or legs, 2.5 cm or less | 11 | $398 | $36 |
2018: 5 services
| Emergency department visit with high level of medical decision making | 790 | $111,858 | $133 |
| Critical care, first 30-74 minutes | 157 | $26,853 | $170 |
| Emergency department visit with moderate level of medical decision making | 104 | $9,584 | $90 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 24 | $2,662 | $111 |
| Emergency department visit with low level of medical decision making | 30 | $1,474 | $49 |
2017: 7 services
| Emergency department visit with high level of medical decision making | 787 | $114,050 | $134 |
| Critical care, first 30-74 minutes | 152 | $27,315 | $174 |
| Emergency department visit with moderate level of medical decision making | 124 | $11,283 | $90 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 15 | $1,829 | $114 |
| Emergency department visit with low level of medical decision making | 35 | $1,763 | $46 |
| Critical care, each additional 30 minutes | 15 | $1,409 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 92 | $656 | $6 |
2016: 4 services
| Emergency department visit with high level of medical decision making | 196 | $27,387 | $137 |
| Critical care, first 30-74 minutes | 33 | $5,945 | $175 |
| Emergency department visit with moderate level of medical decision making | 32 | $2,971 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 17 | $112 | $7 |
Medicaid work
$225,324 in 2024
Medicaid paid $225,324 for 4,251 billed services this clinician did in 2024, up to 68 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 970 | $102,983 |
| EMERGENCY DEPT VISIT MOD MDM | 561 | $65,883 |
| EMERGENCY DEPT VISIT LOW MDM | 90 | $8,489 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 97 | $7,921 |
| Computed tomography, head or brain; without contrast material | 62 | $6,278 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 28 | $6,106 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 81 | $4,163 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 166 | $3,174 |
| COMPREHENSIVE METABOLIC PANEL | 465 | $3,018 |
| Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure) | 82 | $2,609 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 72 | $2,332 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 452 | $2,205 |
| 2024 | 4,251 | 26 | 68 | $225,324 |
| 2023 | 7,199 | 28 | 72 | $324,277 |
| 2022 | 5,693 | 33 | 75 | $246,694 |
| 2021 | 5,369 | 27 | 91 | $216,799 |
| 2020 | 4,233 | 22 | 105 | $193,646 |
| 2019 | 6,386 | 29 | 137 | $262,675 |
| 2018 | 5,775 | 28 | 128 | $253,081 |
See the largest Medicaid services in earlier years
2023
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 1,265 | $128,288 |
| EMERGENCY DEPT VISIT MOD MDM | 840 | $86,921 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 181 | $17,932 |
| EMERGENCY DEPT VISIT LOW MDM | 177 | $16,742 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 46 | $10,775 |
| Computed tomography, head or brain; without contrast material | 91 | $7,967 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 3 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B), upper respiratory specimen, each pathogen reported as detected or not detected | 81 | $6,989 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 106 | $5,491 |
| Intravenous infusion, hydration; each additional hour (List separately in addition to code for primary procedure) | 239 | $5,077 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 355 | $4,821 |
| COMPREHENSIVE METABOLIC PANEL | 689 | $4,587 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 258 | $4,348 |
2022
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 1,113 | $113,204 |
| EMERGENCY DEPT VISIT MOD MDM | 621 | $56,454 |
| EMERGENCY DEPT VISIT LOW MDM | 276 | $20,842 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 128 | $12,586 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) and influenza virus types A and B, multiplex amplified probe technique | 72 | $7,052 |
| Computed tomography, head or brain; without contrast material | 76 | $5,772 |
| COMPREHENSIVE METABOLIC PANEL | 544 | $3,436 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 66 | $3,045 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 14 | $2,683 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 535 | $2,439 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 3 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B), upper respiratory specimen, each pathogen reported as detected or not detected | 19 | $2,282 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 174 | $2,103 |
2021
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 1,126 | $105,351 |
| EMERGENCY DEPT VISIT MOD MDM | 499 | $50,654 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 217 | $21,994 |
| EMERGENCY DEPT VISIT LOW MDM | 189 | $16,283 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 86 | $3,285 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 67 | $2,858 |
| COMPREHENSIVE METABOLIC PANEL | 370 | $2,303 |
| Unclassified drugs | 771 | $1,969 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 145 | $1,654 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 359 | $1,648 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 173 | $1,383 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 513 | $936 |
2020
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 1,264 | $107,607 |
| EMERGENCY DEPT VISIT MOD MDM | 421 | $34,699 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 282 | $28,531 |
| EMERGENCY DEPT VISIT LOW MDM | 164 | $13,498 |
| COMPREHENSIVE METABOLIC PANEL | 366 | $1,974 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 351 | $1,443 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 128 | $1,194 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 27 | $994 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 433 | $666 |
| Unclassified drugs | 180 | $541 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 88 | $519 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 288 | $398 |
2019
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 1,628 | $126,431 |
| EMERGENCY DEPT VISIT MOD MDM | 657 | $67,263 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 230 | $19,996 |
| EMERGENCY DEPT VISIT LOW MDM | 223 | $16,506 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 42 | $3,874 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 100 | $3,513 |
| COMPREHENSIVE METABOLIC PANEL | 527 | $3,462 |
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 12 | $2,910 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 518 | $2,504 |
| Computed tomography, head or brain; without contrast material | 30 | $2,207 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 194 | $2,104 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 270 | $2,080 |
2018
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 1,331 | $120,729 |
| EMERGENCY DEPT VISIT MOD MDM | 663 | $61,194 |
| EMERGENCY DEPT VISIT LOW MDM | 366 | $24,721 |
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 178 | $17,359 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 95 | $4,268 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 42 | $3,692 |
| COMPREHENSIVE METABOLIC PANEL | 471 | $3,659 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 194 | $2,228 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 391 | $2,077 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure) | 89 | $1,681 |
| Computed tomography, head or brain; without contrast material | 14 | $1,661 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug | 147 | $1,364 |
Drugs they prescribed that Part D paid
$2,631
Pharmacies billed $2,631 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 16% of their Part D prescriptions (31 of 195) in 2024. Above the middle of the specialty; the typical emergency medicine clinician is at 12%.
187 generic and fewer than 11 brand-name prescriptions · $2,631 in drug cost · 45 antibiotic prescriptions to 39 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cefdinir | 16 | $326 | $20 |
| Ondansetron Odt | 21 | $190 | $9 |
| Hydrocodone-Acetaminophen | 18 | $77 | $4 |
Year by year
| 2024 | 195 | 112 | 16% (31) | None | $2,631 |
| 2023 | 215 | 122 | 15% (32) | None | $3,890 |
| 2022 | 203 | 107 | 17% (35) | None | $6,498 |
| 2021 | 234 | 128 | 16% (37) | None | $3,846 |
| 2020 | 266 | 158 | 15% (41) | 4% | $3,697 |
| 2019 | 357 | 221 | 16% (56) | 8% | $9,430 |
| 2018 | 333 | 212 | 18% (59) | 11% | $5,009 |
| 2017 | 388 | 236 | 21% (83) | 11% | $5,520 |
| 2016 | 102 | 61 | 20% (20) | None | $830 |
| 2015 | 53 | 39 | None | None | $2,785 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Cefdinir | 15 | $393 | $26 |
| Ketorolac Tromethamine | 12 | $219 | $18 |
| Ondansetron Odt | 17 | $143 | $8 |
| Hydrocodone-Acetaminophen | 18 | $94 | $5 |
2022: 3 drugs
| Ondansetron Odt | 19 | $138 | $7 |
| Hydrocodone-Acetaminophen | 22 | $95 | $4 |
| Cephalexin | 12 | $81 | $7 |
2021: 3 drugs
| Cefdinir | 18 | $303 | $17 |
| Hydrocodone-Acetaminophen | 28 | $200 | $7 |
| Ondansetron Odt | 20 | $119 | $6 |
2020: 4 drugs
| Cefdinir | 32 | $875 | $27 |
| Ondansetron Odt | 23 | $266 | $12 |
| Hydrocodone-Acetaminophen | 28 | $168 | $6 |
| Doxycycline Hyclate | 12 | $157 | $13 |
2019: 9 drugs
| Cefdinir | 21 | $431 | $21 |
| Ondansetron Odt | 40 | $380 | $9 |
| Diclofenac | 11 | $255 | $23 |
| Hydrocodone-Acetaminophen | 37 | $175 | $5 |
| Methylprednisolone | 12 | $150 | $12 |
| Nitrofurantoin Mono-Macro | 11 | $144 | $13 |
| Amoxicillin-Clavulanate Potass | 11 | $105 | $10 |
| Sucralfate | 13 | $96 | $7 |
| Levofloxacin | 11 | $86 | $8 |
2018: 8 drugs
| Cefdinir | 20 | $363 | $18 |
| Levofloxacin | 22 | $316 | $14 |
| Nitrofurantoin Mono-Macro | 13 | $193 | $15 |
| Hydrocodone-Acetaminophen | 35 | $155 | $4 |
| Ondansetron Odt | 23 | $130 | $6 |
| Ciprofloxacin | 12 | $77 | $6 |
| Tramadol | 18 | $57 | $3 |
| Prednisone | 12 | $48 | $4 |
2017: 10 drugs
| Ventolin Hfa | 12 | $640 | $53 |
| Hydrocodone-Acetaminophen | 57 | $273 | $5 |
| Nitrofurantoin Mono-Macro | 17 | $228 | $13 |
| Ondansetron Odt | 33 | $210 | $6 |
| Levofloxacin | 23 | $180 | $8 |
| Prednisone | 21 | $72 | $3 |
| Cephalexin | 18 | $72 | $4 |
| Ciprofloxacin | 12 | $53 | $4 |
| Tramadol | 15 | $37 | $2 |
| Sulfamethoxazole-Trimethoprim | 11 | $21 | $2 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 12 | $64 | $5 |
Money from drug and device companies
$73 in 2019
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Xarelto | $54 | 3 payments
|
| CSL Behring | Kcentra | $19 | 1 payment
|
See all 4 published payments
| Janssen Pharmaceuticals | Meals · 2019-07-02 | Xarelto | $19 |
| Janssen Pharmaceuticals | Meals · 2019-06-19 | Xarelto | $20 |
| CSL Behring | Meals · 2019-03-28 | Kcentra | $19 |
| Janssen Pharmaceuticals | Meals · 2019-03-19 | Xarelto | $14 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 87.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1487098968
- Licence
- LA 303372
- Trained
- Louisiana State University School of Medicine in Shreveport, 2009
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207P00000X (207P00000X); Student in a training program (390200000X)
- Mailing address
- 25 Rio Robles E, #218, San Jose, CA, 95134
- NPI first listed
- 2013-04-26
- NPI last updated
- 2016-08-18
This is when the NPI record was last certified, not a medical board exam.